Keith Westby
Chief Operating Officer chez IVERIC BIO, INC.
Profil
Keith Westby is currently the Chief Operating Officer & Senior Vice President at IVERIC bio, Inc. He previously worked as the Director-Alliance & Project Management at Oldtech, Inc. and as the Director-Project Alliance & Management at Pharmasset, Inc. He also held the position of Vice President-Project Management at IVERIC bio, Inc. Mr. Westby has a graduate degree from Drexel University, an undergraduate degree from State University of New York College at Geneseo, and an MBA from Columbia Business School.
Postes actifs de Keith Westby
| Sociétés | Poste | Début |
|---|---|---|
| IVERIC BIO, INC. | Chief Operating Officer | 29/01/2017 |
Anciens postes connus de Keith Westby
| Sociétés | Poste | Fin |
|---|---|---|
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/08/2007 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Corporate Officer/Principal | 01/12/2005 |
| IVERIC BIO, INC. | Corporate Officer/Principal | - |
Formation de Keith Westby
| Drexel University | Graduate Degree |
| State University of New York College at Geneseo | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
